  Hypervariable T-cell receptors (TCR) play a key role in adaptive immunity,
recognising a vast diversity of pathogen-derived antigens. High throughput
sequencing of TCR repertoires (RepSeq) produces huge datasets of T-cell
receptor sequences from blood and tissue samples. However, our ability to
extract clinically relevant information from RepSeq data is limited, mainly
because little is known about TCR-disease associations. Here we present a
statistical approach called ALICE (Antigen-specific Lymphocyte Identification
by Clustering of Expanded sequences) that identifies TCR sequences that are
actively involved in the current immune response from a single RepSeq sample,
and apply it to repertoires of patients with a variety of disorders -
autoimmune disease (ankylosing spondylitis), patients under cancer
immunotherapy, or subject to an acute infection (live yellow fever vaccine).
The method's robustness is demonstrated by the agreement of its predictions
with independent assays, and is supported by its ability to selectively detect
responding TCR in the memory but not in the naive subset. ALICE requires no
longitudinal data collection nor large cohorts, and is thus directly applicable
to most RepSeq datasets. Its results facilitate the identification of TCR
variants associated with a wide variety of diseases and conditions, which can
be used for diagnostics, rational vaccine design and evaluation of the adaptive
immune system state.
